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Abstract
Protein-protein interactions are fundamental for many biological
processes in the cell. Therefore, their characterization plays an
important role in current research and a plethora of methods for
their investigation is available1. Protein-protein interactions often
are highly dynamic and may depend on subcellular localization,
post-translational modifications and the local protein environment2.
Therefore, they should be investigated in their natural environment,
for which co-immunoprecipitation approaches are the method of
choice3. Co-precipitated interaction partners are identified either by
immunoblotting in a targeted approach, or by mass spectrometry (LC-
MS/MS) in an untargeted way. The latter strategy often is adversely
affected by a large number of false positive discoveries, mainly
derived from the high sensitivity of modern mass spectrometers that
confidently detect traces of unspecifically precipitating proteins. A
recent approach to overcome this problem is based on the idea that
reduced amounts of specific interaction partners will co-precipitate
with a given target protein whose cellular concentration is reduced
by RNAi, while the amounts of unspecifically precipitating proteins
should be unaffected. This approach, termed QUICK for QUantitative
Immunoprecipitation Combined with Knockdown4, employs Stable
Isotope Labeling of Amino acids in Cell culture (SILAC)5 and MS
to quantify the amounts of proteins immunoprecipitated from wild-
type and knock-down strains. Proteins found in a 1:1 ratio can be
considered as contaminants, those enriched in precipitates from
the wild type as specific interaction partners of the target protein.
Although innovative, QUICK bears some limitations: first, SILAC is
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cost-intensive and limited to organisms that ideally are auxotrophic
for arginine and/or lysine. Moreover, when heavy arginine is fed,
arginine-to-proline interconversion results in additional mass shifts for
each proline in a peptide and slightly dilutes heavy with light arginine,
which makes quantification more tedious and less accurate5,6. Second,
QUICK requires that antibodies are titrated such that they do not
become saturated with target protein in extracts from knock-down
mutants.
Here we introduce a modified QUICK protocol which overcomes the
abovementioned limitations of QUICK by replacing SILAC for 15N
metabolic labeling and by replacing RNAi-mediated knock-down for
affinity modulation of protein-protein interactions. We demonstrate
the applicability of this protocol using the unicellular green alga
Chlamydomonas reinhardtii as model organism and the chloroplast
HSP70B chaperone as target protein7 (Figure 1). HSP70s are known
to interact with specific co-chaperones and substrates only in the
ADP state8. We exploit this property as a means to verify the specific
interaction of HSP70B with its nucleotide exchange factor CGE19.
Protocol
1. Antibody Adsorption
1. Weigh out 120 mg of Protein A Sepharose in a 15-ml conical
tube (Falcon). As 15 mg Protein A sepharose is needed for each
immunoprecipitation (IP) this amount is sufficient for 8 IPs. Add 5
ml 0.1 M phosphate buffer (pH 7.4) and let the Protein A Sepharose
swell for 30 min at 4 °C.
(Note that all steps from this point on need to be carried out with
gloves to avoid contamination with keratin and on ice to avoid protein
degradation/complex dissociation.)
1. Centrifuge for 60 sec at 1,000 x g and 4 °C to pellet the swollen
Protein A Sepharose. Carefully remove the supernatant and
resuspend the beads in 5 ml 0.1 M phosphate buffer (pH 7.4). Repeat
this step three times to wash the beads thoroughly.
2. After the last centrifugation step, remove supernatant and leave
approximately 0.5 ml of phosphate buffer. Add 0.9 ml 0.5 M
phosphate buffer (pH 7.4), 400 μl affinity purified primary antibodies
(50 μl per IP) against the target protein (here HSP70B), and 16 μl
antibodies against a control protein (here CF1β). Fill up with ddH2O
to a total volume of 5 ml.
(Note that affinity-purified antibodies should be used to reduce
contamination by unspecific IgGs, which interfere with nano-LC-
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MS analysis - for a protocol see Willmund et al. (2005)10. CF1β is
precipitated as a loading control and was chosen because it is abundant
and, after cell lysis, present in soluble and membrane fractions.
Alternatively, levels of contaminating proteins may be used to normalize
for unequal loading.)
1. Allow Protein A Sepharose beads to adsorb IgGs during a 1-hr
Incubation at 25 °C on a tube roller (CAT RM5W, 36 rpm).
2. Centrifuge for 60 sec at 1,000 x g and 4 °C to pellet the Protein A
Sepharose beads. Carefully remove the supernatant and resuspend
the beads in 5 ml 0.1 M sodium borate buffer (pH 9.0). Repeat this
step three times to thoroughly remove amines that would quench the
crosslinker.
3. Weigh out 25.9 mg of fresh, solid dimethylpimelimidate and
resuspend it in 5 ml 0.1 M sodium borate buffer (pH 9.0) to obtain
a final concentration of 20 mM. Add this solution to the Protein A
Sepharose beads.
4. Allow IgGs to cross-link to Protein A for 30 min at 25 °C on a tube
roller.
5. Centrifuge for 60 sec at 1,000 x g and 4 °C to pellet the beads.
Carefully remove the supernatant and resuspend the beads in 5 ml 1
M Tris-HCl (pH 7.5) to quench free crosslinker. Repeat this step once
and incubate for 2 hr at 25 °C or 12-24 hr at 4 °C on a tube roller.
6. Optional: if Protein A Sepharose beads coupled to IgGs are not
directly used for IP, storage for up to one week is possible. For
this, centrifuge for 60 sec at 1,000 x g and 4 °C to pellet the beads,
carefully remove the supernatant and resuspend beads in 5 ml 0.1 M
phosphate buffer (pH 7.5) containing 0.02% sodium azide and store
at 4 °C until further use.
2. Cell Lysis, Crosslinking and Sample Preparation
1. Grow two Chlamydomonas cultures in medium containing 7.5 mM
14NH4Cl or 15NH4Cl as nitrogen source to a density of ~5 x 106
cells/ml. Cells need to pass through at least ten generations for
full labeling. Here, cells were grown photomixotrophically in TAP
medium11 on a rotatory shaker at 25 °C under continuous irradiation
with white light (30 μE m-2 s-1).
2. Transfer two aliquots each of 14N- and 15N-labeled cells to four
GSA tubes and harvest cells by a 4-min centrifugation at 4,000 x
g and 4 °C (The cell number harvested for each aliquot depends
on the cellular concentration of the target protein and needs to be
determined empirically in advance to ensure that sufficient target
protein is precipitated. A good starting point is 109 cells per aliquot,
i.e., 200 ml of a culture with 5 x 106 cells/ml.)For crosslinking
only: in case protein complexes will be crosslinked prior to IP, cells
need to be washed to remove amines present in the medium. For
this, resuspend cells in 40 ml pre-cooled KH buffer (20 mM HEPES-
KOH (pH 7.2), 80 mM KCl) and transfer them to 50-ml Falcon tubes.
Centrifuge for 60 sec at 1,000 x g and 4 °C. Repeat this step once.
3. Resuspend cells in 2 ml Lysis buffer (20 mM HEPES-KOH (pH 7.2),
1 mM MgCl2, 10 mM KCl, 154 mM NaCl) pre-cooled to 4 °C and
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transfer them to 15-ml Falcon tubes. Collect remaining cells in
GSA tubes with an additional 1 ml Lysis buffer each. Add 50 μl 25 x
protease inhibitor and 12.5 μl 1 M MgCl2 (to a final concentration of
3.5 mM) to each aliquot.
4. Add 150 μl Lysis buffer, 12.5 μl 1 M ATP, 833 μl 270 mM creatine
phosphate and 7 μl 5 μg/μl creatine phosphokinase (the final
concentration is 2.5 mM ATP, 45 mM creatine phosphate, and 7 μg/
ml creatine phosphokinase) to one of the aliquots containing 14N- and
15N-labeled cells (these are the +ATP aliquots).
5. Add 930 μl Lysis buffer and 70 μl 1 U/μl apyrase to the other aliquots
containing 14N- and 15N-labeled cells (these are the -ATP aliquots).
6. Incubate for 2 min at 25 °C on a tube roller to establish ATP-deplete
and ATP-replete states. If the crosslinking step is omitted, add
another 1 ml of Lysis buffer. For crosslinking only: in case the
investigated protein-protein interactions are transient it is advisable
to capture them by a crosslinking step. For this, add 500 μl 20 mM
dithio-bis(succinimidyl propionate) (DSP) dissolved in DMSO (final
concentration is 2 mM) to each tube directly before sonication.
7. Sonicate four times 20 sec on ice to break cells with 20-sec breaks
in between for cooling. (We use the Bandelin Sonoplus HD2070
with a KE76 tip at output control of 75% and duty cycle of 60%.
The necessary settings for other machines/devices/tips need to be
determined in advance to ensure complete cell lysis and to avoid
spilling.) For crosslinking only: allow protein complexes to cross-
link by incubating for 1 hr at 4 °C on a tube roller. After crosslinking,
supplement each tube with 500 μl 1 M glycine and incubate on a
tube roller for another 15 min at 4 °C to quench free crosslinker.
8. Prepare four 6-ml sucrose cushions (20 mM HEPES-KOH (pH 7.2),
0.6 M sucrose) in SW41 Ti thin wall tubes (Beckman Coulter Item
No: 344059), carefully lay the entire ~5.5 ml of cell lysates onto the
sucrose cushions (balance with Lysis buffer) and centrifuge for 30
min at 200,000 x g and 4 °C in a SW41 Ti rotor.
9. Transfer the top of the gradient containing soluble protein complexes
into four 15-ml Falcon tubes (avoid transferring parts of the sucrose
cushion), add 350 μl 10% Triton X-100 to a final concentration of
0.5% to each of them, mix carefully and add Lysis buffer to a total
volume of 7 ml each. (Transfer 70 μl of each soluble cell extract to
fresh 1.5-ml conical tubes (Eppendorf tubes) and add 70 μl 2 x SDS-
sample buffer (4% SDS, 125 mM Tris-HCl (pH 6.8), 20% glycerol,
10% 2-mercaptoethanol) to each for SDS-PAGE and immunoblot
analyses.)
10.Discard the sucrose cushions and resuspend the membrane pellets
in 3 ml Lysis buffer each. Add to each 1 ml 10% Triton X-100 to a
final concentration of 2%, sonicate on ice to dissolve pellets, and add
Lysis buffer to a total volume of 5 ml each.
11.Prepare another four 6-ml sucrose cushions in SW41 Ti thin wall
tubes, lay the ~5 ml of solubilized membranes from step 2.10
carefully onto the sucrose cushions, and centrifuge for 30 min at
200,000 x g and 4 °C in a SW41 Ti rotor.
12.Transfer the top of the gradient containing membrane protein
complexes into four 15-ml Falcon tubes and add Lysis buffer
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(containing 2% Triton X-100) to a final volume of 7 ml each. (Transfer
70 μl of each soluble cell extract to fresh Eppendorf tubes and
add 70 μl 2 x SDS-sample to each for SDS-PAGE and immunoblot
analyses.)
3. Immunoprecipitation
1. Pellet the Protein A Sepharose beads containing coupled antibodies
(from steps 1.8 or 1.9) by a 60-sec centrifugation at 1,000 x g and
4 °C, carefully remove the supernatant and resuspend beads in 4
ml Lysis buffer. Repeat this step twice to equilibrate beads in Lysis
buffer.
2. Fill up to 8 ml with Lysis buffer and transfer 1 ml of the suspension
to each of the eight 15-ml Falcon tubes containing soluble or
membrane protein complexes from ATP-replete and ATP-deplete 14N-
and 15N-labeled cells (from step 2.9 and 2.12).
3. Incubate for 2 hr at 4 °C on a tube roller to precipitate protein
complexes.
4. Pellet the beads by a 60-sec centrifugation at 1,000 x g and 4 °C and
discard the supernatants. Leave a small volume of liquid on top of
the beads to facilitate transfer.
5. Transfer the beads from each Falcon tube to 1.5-ml conical tubes
(Eppendorf tubes). To collect all remaining beads in the Falcon
tubes, add another 0.8 ml Lysis buffer containing 0.1% Triton to
each, vortex gently, centrifuge for 60 sec at 1,000 x g and 4 °C and
transfer the buffer with residual beads to the Eppendorf tubes. Tube
exchange is necessary to prevent contaminations from proteins
adhering to the plastic walls.
6. Pellet the beads by a 15-sec centrifugation at 16,100 x g and 4 °C,
carefully remove the supernatants and resuspend beads in 1.3 ml
Lysis buffer containing 0.1% Triton. Repeat this step twice with lysis
buffer containing Triton and twice with Lysis buffer lacking Triton to
thoroughly wash the beads. Leave a small volume of liquid on top of
the beads to facilitate transfer.
7. Again transfer the beads to fresh 1.5-ml Eppendorf tubes to remove
proteins adhering to the plastic walls. Wash the old tubes with 1
ml Lysis buffer lacking Triton and transfer all residual beads to the
fresh tubes.
8. Centrifuge for 15 sec at 16,100 x g and 4 °C, remove the
supernatants first with a normal pipette, then remove any remaining
supernatant completely with a 50-μl Hamilton syringe.
4. Sample Preparation for nano-LC-MS/MS
1. Add 100 μl freshly prepared Elution buffer (8 M urea, 25 mM
NH4HCO3) to each tube, use the 100 μl Elution buffer to wash off
beads sticking to the Hamilton syringe and incubate for 10 min in
a thermomixer at 800 rpm and 65 °C, and for another 20 min at 30
°C. (A much more complete elution of bound proteins is achieved
by elution with 2% SDS and subsequent precipitation with 80%
acetone.)
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2. Centrifuge for 15 sec at 16,100 x g and 25 °C. Transfer supernatants
to fresh tubes with a 50-μl Hamilton syringe.
3. Add 50 μl Elution buffer to the beads, use the 50 μl Elution buffer to
wash off beads sticking to Hamilton syringe and repeat incubation
and centrifugation steps 4.1 and 4.2, respectively. Pool the respective
eluates. (Transfer 30 μl of the eluates to fresh Eppendorf tubes, add
30 μl 2 x SDS-sample buffer to each for SDS-PAGE and immunoblot
analyses.)
4. Combine the eluted precipitates from +/-ATP-treated, 14N- and 15N-
labeled soluble and membrane proteins as follows: 120 μl 15N/+ATP
and 120 μl 14N/-ATP 120 μl 14N/+ATP and 120 μl 15N/-ATP 120 μl 15N/
+ATP and 120 μl 14N/-ATP 120 μl 14N/+ATP and 120 μl 15N/-ATP
5. Add 1.5 μl freshly prepared 1 M DTT to a final concentration of
6.5 mM to each of the four combinations to reduce disulfide bonds
(including those in the crosslinker) and incubate for 30 min at 25 °C.
6. Add 10.5 μl freshly prepared 0.6 M iodoacetamide to a final
concentration of 25 mM to carboxymethylate the reduced thiols and
incubate for 20 min at 25 °C in the dark.
7. Add 256 μl 40 mM NH4HCO3 and 4 μl Lys-C (0.1 μg/μl), seal tubes
with parafilm, and incubate for at least 16 hr overnight on a rotation
wheel at 37 °C.
8. Add 470 μl 20 mM NH4HCO3, 10 μl 100 % acetonitrile (to a final
concentration of 1%) and 8 μl trypsin beads, and incubate on a
rotation wheel for at least 16 hr at 37 °C.
9. Centrifuge for 5 min at 16,100 x g and 4 °C, and transfer
supernatants to fresh 2-ml Eppendorf tubes. Wash the old tubes
with 50 μl 20 mM NH4HCO3, 0.5% acetic acid, and pool with first
supernatants.
10.For desalting, prepare homemade C18-StageTips by cutting out two
discs from Empore C18 material with a syringe needle and placing
them in a 200-μl pipette tip. In this way prepare four 200-μl tips.
Punch holes into the lids of four 2-ml Eppendorf tubes and insert
tips.
11.Precondition the C18-StageTips with 50 μl Solution B (80%
acetonitrile, 0.5% acetic acid). Centrifuge for 3 min at 800 g and 25
°C.
12.Equilibrate the C18-StageTips with 100 μl Solution A (0.5% acetic
acid, 2% acetonitrile). Centrifuge for 3 min at 800 g and 25 °C.
Repeat this step once.
13.Load 100 μl of the supernatants from the tryptic digestions (4.9)
on the C18-StageTips and centrifuge for 3 min at 800 g and 25 °C.
Repeat this step until the complete supernatants were applied to the
columns.
14.Wash the C18-StageTips with 100 μl Solution A. Centrifuge for 3 min
at 800 g and 25 °C. Repeat this step twice.
15.Elute tryptic peptides into a fresh 1.5-ml Eppendorf tube with 50 μl
Solution B. Centrifuge for 3 min at 800 g and 25 °C. Repeat this step
once. Dry peptides to completion in a speed vac.
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16.Optional: seal Eppendorf tubes with parafilm and store at -80 °C
until further use.
17.Resuspend the dried peptides with 20 μl Solution A and incubate
for at least 1 hr on ice, interrupted by two 15-min incubations in a
sonicator bath. Centrifuge for 20 min at 16,100 x g and 4 °C, and
apply supernatant to nano-LC-MS/MS.
5. Representative Results
As shown exemplarily for the 14N-labeled cell extracts in Figure 2A,
HSP70B and CGE1 are almost exclusively localized to the soluble
fraction, independent of the ATP state. In contrast, CF1β is localized to
soluble and membrane-enriched fractions, as sonication shears part of
it from membrane-located CFo, and therefore serves as loading control
for both fractions. As shown in Figure 2B, similar amounts of HSP70B
were precipitated with the anti-HSP70B antibodies from 14N- and 15N-
labeled soluble extracts, independent of the ATP state. In contrast, only
little HSP70B was precipitated from membrane fractions with slightly
larger amounts originating from ATP-depleted membrane fractions as
compared to ATP replete fractions, hence corroborating earlier results9.
No CGE1 was co-precipitated with HSP70B in ATP-replete soluble or
membrane fractions, while large amounts of CGE1 were co-precipitated
with HSP70B from ATP-depleted soluble fractions, and little from ATP-
depleted membrane fractions.
The interaction of CGE1 with HSP70B only in the ADP state is also
observed in the MS analysis: in Figure 3, representative MS1 spectra
of HSP70B and CGE1 peptides from precipitates generated with
the HSP70B antiserum from soluble cell extracts are shown. In the
experiment shown in Figure 3A, precipitates were from mixtures of
14N-labeled extracts lacking ATP and 15N-labeled extracts containing
ATP. While the heavy and light labeled form of the HSP70B peptide were
detected at equal intensities, only the light labeled form of the CGE1
peptide (from -ATP extracts) was found. In Figure 3B the same peptides
from the anti-HSP70B precipitate derived from mixtures of reciprocally
labeled soluble cell extracts are shown. Accordingly, this time only
the heavy labeled form of the CGE1 peptide (from -ATP extracts) was
detected, while this was again the case for both, light and heavy labeled
HSP70B peptides.
Figure 1. Experimental workflow. Cells are metabolically labeled with
14N and 15N for at least 10 generations, harvested and supplied with or
depleted from ATP. After cell lysis protein complexes optionally may be
crosslinked (X-link) with DSP. Lysed cells are then separated in soluble
(Sol) and membrane enriched (Pel) fractions. Target proteins (here
HSP70B) and a control protein (here CF1β) are immunoprecipitated with
specific antibodies coupled to protein A sepharose beads (black). After
washing, precipitated proteins are eluted and either directly analyzed
by immunoblotting, or the respective 14N- and 15N-labeled fractions in
+ATP and -ATP states are pooled, digested and analyzed by nano-LC-
MS/MS. In the example case shown here the 15N-labeled fraction was
depleted from ATP. Accordingly, the ratio of intensities of heavy labeled
(dark colors) to light labeled (light colors) peptides from the control
protein (CF1β), the target protein (HSP70B) and non-specifically bound
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contaminants should be around one, while this ratio is expected to be
very high for proteins specifically interacting with the target protein
(CGE1).  Click here to view larger figure.
Figure 2. A Analysis of the input for HSP70B
immunoprecipitation. Total protein was extracted from soluble
(Sol) and membrane enriched (Pel) fractions either depleted from ATP
(-ATP) or supplemented with ATP and an ATP regenerating system
(+ATP). 0.01% of the protein extracts were separated on a 10% SDS-
polyacrylamide gel, and levels of HSP70B and CGE1 protein relative
to loading control CF1β were analyzed by immunoblotting. B Analysis
of immunoprecipitates. HSP70B was immunoprecipitated from
14N- and 15N-labeled soluble and membrane-enriched cell extracts
containing or lacking ATP. Proteins corresponding to 3.3% of the
immunoprecipitates were separated on a 10% SDS-polyacrylamide gel
and levels of HSP70B and CGE1 relative to loading control CF1β were
analyzed by immunoblotting.  Click here to view larger figure.
Figure 3. A Representative mass spectra of HSP70B and CGE1
peptides from anti-HSP70B immunoprecipitates performed on
mixed soluble fractions (14N -ATP/15N +ATP). Full MS spectra of 14N
and 15N labeled peptides, corresponding to the -ATP and +ATP states,
respectively, from HSP70B and co-immunoprecipitated CGE1 are shown.
Both peptides are triply charged, the HSP70B peptide contains 22
nitrogen atoms, the CGE1 peptide 19, corresponding to a mass shift of
7.33 and 6.33 m/z, respectively. B Representative mass spectra from
the reciprocal experiment (14N +ATP/15N -ATP). Full MS spectra of
the same 14N and 15N labeled peptides, here corresponding to the +ATP
and -ATP states, respectively, from HSP70B and co-immunoprecipitated
CGE1 are shown.  Click here to view larger figure.
Discussion
We have recently introduced two improvements to the QUICK approach:
a crosslinking step for capturing transient protein-protein interactions
(QUICK-X), and a control precipitation to normalize for unequal
precipitation efficiencies6. Here we present a protocol containing
two more improvements of QUICK: first, we replace SILAC5 for 15N
metabolic labeling. The advantages are that 15N metabolic labeling is
much cheaper than SILAC, if 15N is provided as simple inorganic salt.
Furthermore, with 15N metabolic labeling QUICK can be applied to
organisms prototrophic for all amino acids, like most plants, fungi and
bacteria. And finally, arginine-to-proline interconversion inherent to
SILAC5,6 does not present a problem for quantification of 15N labeled
peptides. Examples for suitable tools for the quantitative evaluation of
15N proteomics data are MSQUANT12 or IOMIQS13.
Second, we introduce affinity modulation as a means for specifically
reducing the amount of proteins interacting with a given target protein
in one sample versus another. The advantages of this approach are that
it circumvents the construction of knockdown mutants, which for some
model systems are difficult to generate or cannot be generated at all in
case of essential target proteins. Moreover, it avoids misinterpretations
caused by differential protein expression potentially occurring as a
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response of the cell to knocking-down a target protein: if other proteins
are down-regulated as well and cross-react with the antiserum used
for immunoprecipitation, they would be interpreted as true interaction
partners of the target protein. At last, affinity modulation abolishes the
need of finding a proper antibody-to-antigen ratio.
Although we apply our protocol to Chlamydomonas reinhardtii as
model organism, it can easily be adapted to any other organism that
can be grown in cell culture and is able to use ammonium or nitrate
as nitrogen source. Affinity modulation of protein complexes by ATP/
ADP may directly be applied to other chaperones whose interaction with
substrates and cohort proteins depends on the ATP state, like the GroEL/
HSP60/Cpn60 or HSP90 chaperone systems14,15, or to any other system
where binding affinities are modulated by ATP. Affinity modulation
should also work for cases where affinities between protein interactions
are altered by specific drugs, like radicicol or geldanamycin in the case
of HSP90 systems15.
A clear limitation of our protocol is that it requires affinity-purified
antibodies against a target protein known to be sensitive to a specific
treatment/drug that modulates its affinity for partner proteins.
Therefore, it is no high-throughput method.
Disclosures
No conflicts of interest declared.
Acknowledgements
We thank Olivier Vallon for the antiserum against CF1β. This work was supported
by the Max Planck Society and grants from the Deutsche Forschungsgemeinschaft
(Schr 617/5-1) and the Bundesministerium für Bildung und Forschung (Systems
Biology Initiative FORSYS, project GoFORSYS).
References
1 Perrakis A Musacchio A Cusack S Petosa C Investigating a macromolecular
complex: the toolkit of methods J. Struct. Biol 2011 175 106 112 21620973
2 Gavin AC Maeda K Kuhner S Recent advances in charting protein-protein
interaction: mass spectrometry-based approaches Curr. Opin. Biotechnol
2011 22 42 49 20934865
3 Markham K Bai Y Schmitt-Ulms G Co-immunoprecipitations revisited: an
update on experimental concepts and their implementation for sensitive
interactome investigations of endogenous proteins Anal. Bioanal. Chem 2007
389 461 473 17583802
4 Selbach M Mann M Protein interaction screening by quantitative
immunoprecipitation combined with knockdown (QUICK Nat Methods 2006 3
981 983 17072306
5 Ong SE Mann M A practical recipe for stable isotope labeling by amino acids in
cell culture (SILAC) Nat Protoc 2006 1 2650 2660 17406521
6 Heide H Application of quantitative immunoprecipitation combined with
knockdown and cross-linking to Chlamydomonas reveals the presence of
vesicle-inducing protein in plastids 1 in a common complex with chloroplast
HSP90C Proteomics 2009 9 3079 3089 19526558
10 A Protocol for the Identification of Protein-protein Interactions Based on 15N
Metabolic Labeling, Immunoprecipitation, Quantitative Mass Spectrometry and
Affinity Modulation
7 Nordhues A Miller SM Muhlhaus T Schroda M New insights into the roles of
molecular chaperones in Chlamydomonas and Volvox International review of
cell and molecular biology 2010 285 75 113 21035098
8 Mayer MP Bukau B Hsp70 chaperones: cellular functions and molecular
mechanism Cell Mol. Life Sci 2005 62 670 684 15770419
9 Schroda M Vallon O Whitelegge JP Beck CF Wollman FA The chloroplastic GrpE
homolog of Chlamydomonas: two isoforms generated by differential splicing
The Plant Cell 2001 13 2823 2839 11752390
10 Willmund F Schroda M HEAT SHOCK PROTEIN 90C is a bona fide Hsp90 that
interacts with plastidic HSP70B in Chlamydomonas reinhardtii Plant Physiol
2005 138 2310 2322 15995001
11 Harris EH The Chlamydomonas Sourcebook: Introduction to Chlamydomonas
and Its Laboratory Use 2008 San Diego, CA Elsevier, Academic Press
12 Mortensen P MSQuant, an open source platform for mass spectrometry-based
quantitative proteomics J. Proteome Res 2010 9 393 403 19888749
13 M?hlhaus T Weiss J Hemme D Sommer F Schroda M Quantitative Shotgun
Proteomics Using a Uniform 15N-Labeled Standard to Monitor Proteome
Dynamics in Time Course Experiments Reveals New Insights into the Heat
Stress Response of Chlamydomonas reinhardtii Mol. Cell Proteomics 2011 10
14 Bukau B Horwich AL The Hsp70 and Hsp60 chaperone machines Cell 1998 92
351 366 9476895
15 Wandinger SK Richter K Buchner J The Hsp90 chaperone machinery J. Biol.
Chem 2008 283 18473 18477 18442971
